Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale EVP, Gen. Counsel & Secy. sold 10,000 shares at $272.81 ($2,728,136)
  2. 4 Shares withheld for taxes SVP, Human Resources gave up 66 shares (to pay taxes)
  3. 4 Shares withheld for taxes SVP, Business Development gave up 317 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP & CCO gave up 249 shares (to pay taxes)
  5. 4 Shares withheld for taxes VP, Finance & CAO gave up 249 shares (to pay taxes)
  6. 4 Grant or award Director acquired 240.87 shares (grant or award)
  7. 4 Grant or award Director acquired 296.45 shares (grant or award)
  8. 4 Grant or award Director acquired 240.87 shares (grant or award)
  9. 4 Shares withheld for taxes EVP & CFO gave up 3,502 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP, Gen. Counsel & Secy. gave up 1,751 shares (to pay taxes)
  11. 4 Open-market buy 10% owner bought 1,764,705 shares at $17.00 ($29,999,985)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale EVP, Global Commercial Ops sold 9,558 shares at $262.43 ($2,508,306)
  15. 4 Grant or award Director acquired 153.37 shares (grant or award)
  16. 4 Grant or award Director acquired 124.62 shares (grant or award)
  17. 4 Grant or award Director acquired 124.62 shares (grant or award)
  18. 4 Shares withheld for taxes SVP & CCO gave up 1,129 shares (to pay taxes)
  19. 4 Grant or award Director acquired 939 shares (grant or award)
  20. 4 Grant or award Director acquired 939 shares (grant or award)

Page 14 of 99 · 1,961 filings